AU2003256209A1 - Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents - Google Patents
Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agentsInfo
- Publication number
- AU2003256209A1 AU2003256209A1 AU2003256209A AU2003256209A AU2003256209A1 AU 2003256209 A1 AU2003256209 A1 AU 2003256209A1 AU 2003256209 A AU2003256209 A AU 2003256209A AU 2003256209 A AU2003256209 A AU 2003256209A AU 2003256209 A1 AU2003256209 A1 AU 2003256209A1
- Authority
- AU
- Australia
- Prior art keywords
- eta
- identification
- methods
- protein kinase
- human protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202608-6 | 2002-09-04 | ||
SE0202608A SE0202608D0 (sv) | 2002-09-04 | 2002-09-04 | New sequences |
PCT/SE2003/001361 WO2004022592A1 (en) | 2002-09-04 | 2003-09-03 | Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003256209A1 true AU2003256209A1 (en) | 2004-03-29 |
Family
ID=20288884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003256209A Abandoned AU2003256209A1 (en) | 2002-09-04 | 2003-09-03 | Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003256209A1 (sv) |
SE (1) | SE0202608D0 (sv) |
WO (1) | WO2004022592A1 (sv) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007089546A (ja) * | 2005-09-30 | 2007-04-12 | Univ Of Tokushima | 関節リウマチ感受性遺伝子、及び関節リウマチ罹患リスクの測定方法 |
EP2017355A4 (en) | 2006-04-25 | 2010-01-06 | Univ Kyushu Nat Univ Corp | ASSOCIATED WITH ARTERIOSCLEROSIS DISEASE AND USE THEREOF |
IL305820A (en) * | 2017-02-19 | 2023-11-01 | Nat Inst Biotechnology Negev Ltd | Peptide kinase inhibitors and methods of using them |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050170343A1 (en) * | 2001-01-12 | 2005-08-04 | Cynthnia Seidel-Dugan | Modulating insulin receptor signaling |
-
2002
- 2002-09-04 SE SE0202608A patent/SE0202608D0/sv unknown
-
2003
- 2003-09-03 AU AU2003256209A patent/AU2003256209A1/en not_active Abandoned
- 2003-09-03 WO PCT/SE2003/001361 patent/WO2004022592A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004022592A1 (en) | 2004-03-18 |
SE0202608D0 (sv) | 2002-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1501514A4 (en) | PROTEIN-KINASE MODULATORS AND METHODS OF USE | |
PL375447A1 (en) | Protein kinase inhibitors and uses thereof | |
AU2002310187A1 (en) | Inhibitors of protein kinase for the treatment of disease | |
AU2003283786A1 (en) | Surgical tools and techniques for stimulation | |
EP1511730B8 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
AU2003272601B2 (en) | Sustained-release opioid formulations and methods of use | |
AU2003261251A1 (en) | Methods of delivering therapeutic agents | |
IL176737A0 (en) | Pyrazolo[1,5-a] pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases | |
AU2003235676A1 (en) | Tricyclic-bis-enone derivatives and methods of use thereof | |
AU2003223579A1 (en) | Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease | |
AU2001270260A1 (en) | 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors | |
AU2003216592A8 (en) | Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases | |
AU2002317105A1 (en) | Methods for identifying therapeutic agents for treating diseases involving wnt polypeptides and wnt receptors | |
AU2003298937A1 (en) | Heterocyclic compounds, methods of making them and their use in therapy | |
AU2003289742A1 (en) | Stable therapeutic proteins | |
AU2001292019A1 (en) | Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease | |
AU2003210983A1 (en) | Kinase inhibitors and methods of use thereof | |
AU2002352007A1 (en) | Agents and methods for detecting human adenoviruses | |
AU2003226899A1 (en) | Human diabetes-mediating proteins | |
AU2004229218B2 (en) | Thorium-227 for use in radiotherapy of soft tissue disease | |
AU2003256209A1 (en) | Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents | |
AU2002341828A1 (en) | Enhanced proteins and methods for their use | |
AU2003244455A1 (en) | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases | |
AU2003284597A1 (en) | Apoptosis-associated protein and use thereof | |
AU2003293839A1 (en) | Method for determining markers of human facial skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |